The role of RNA uptake in platelet heterogeneity

Thrombosis and Haemostasis

Volumn 117, Issue 5, 2017, Pages 948-961

  Clancy, Lauren ^a   Beaulieu, Lea M ^a   Tanriverdi, Kahraman ^a   Freedman, Jane E ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Platelet physiology; Platelets; RNA transfer; RNA uptake

Indexed keywords

RNA; MESSENGER RNA; TLR2 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2;

APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL INTERACTION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; FLUORESCENCE IMAGING; GENE EXPRESSION ASSAY; HEMOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; T LYMPHOCYTE ACTIVATION; THROMBOCYTE; THROMBOCYTE ACTIVATION; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND HEALING; ANIMAL; BLOOD; C57BL MOUSE; CELL SIZE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; RNA STABILITY; RNA TRANSPORT;

ANIMALS; APOPTOSIS; BLOOD PLATELETS; CELL SIZE; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE, INBRED C57BL; MICE, KNOCKOUT; RNA STABILITY; RNA TRANSPORT; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TRANSCRIPTION, GENETIC;

EID: 85019609933     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH16-11-0873     Document Type: Article

References (52)

1. Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science 2010; 328: 562-564.
2. Rowley JW, Oler AJ, Tolley ND, et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 2011; 118: e101-111.
3. Bray PF, McKenzie SE, Edelstein LC, et al. The complex transcriptional landscape of the anucleate human platelet. BMC Genomics 2013; 14: 1.
4. Freedman JE, Larson MG, Tanriverdi K, et al. Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study. Circulation 2010; 122: 119-129.
5. Lood C, Amisten S, Gullstrand B, et al. Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. Blood 2010; 116: 1951-1957.
6. Jain S, Kapetanaki MG, Raghavachari N, et al. Expression of regulatory platelet microRNAs in patients with sickle cell disease. PLoS One 2013; 8: e60932.
7. Healy AM, Pickard MD, Pradhan AD, et al. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 2006; 113: 2278-2284.
8. Gidlof O, van der Brug M, Ohman J, et al. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood 2013; 121: 3908-3917, S1-26.
9. Kahr WH, Hinckley J, Li L, et al. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet 2011; 43: 738-740.
10. Nilsson RJ, Balaj L, Hulleman E, et al. Blood platelets contain tumour-derived RNA biomarkers. Blood 2011; 118: 3680-3683.
11. Gnatenko DV, Zhu W, Xu X, et al. Class prediction models of thrombocytosis using genetic biomarkers. Blood 2010; 115: 7-14.
12. Simon LM, Edelstein LC, Nagalla S, et al. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood 2014; 123: e37-45.
13. Koupenova M, Mick E, Mikhalev E, et al. Sex differences in platelet toll-like receptors and their association with cardiovascular risk factors. Arterioscler Thromb Vasc Biol 2015; 35: 1030-1037.
14. Weyrich AS, Schwertz H, Kraiss LW, et al. Protein synthesis by platelets: historical and new perspectives. J Thromb Haemost 2009; 7: 241-246.
15. Zimmerman GA, Weyrich AS. Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol 2008; 28: s17-24.
16. Angenieux C, Maitre B, Eckly A, et al. Time-Dependent Decay of mRNA and Ribosomal RNA during Platelet Aging and Its Correlation with Translation Activity. PLoS One 2016; 11: e0148064.
17. Londin ER, Hatzimichael E, Loher P, et al. The human platelet: strong transcriptome correlations among individuals associate weakly with the platelet proteome. Biol Direct 2014; 9: 3.
18. Risitano A, Beaulieu LM, Vitseva O, Freedman JE. Platelets and platelet-like particles mediate intercellular RNA transfer. Blood 2012; 119: 6288-6295.
19. Laffont B, Corduan A, Rousseau M, et al. Platelet microparticles reprogram macrophage gene expression and function. Thromb Haemost 2016; 115: 311-323.
20. Ault KA, Rinder HM, Mitchell J, et al. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol 1992; 98: 637-646.
21. Harrison P, Robinson MS, Mackie IJ, Machin SJ. Reticulated platelets. Platelets 1997; 8: 379-383.
22. Patel SR, Hartwig JH, Italiano JE, Jr. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 2005; 115: 3348-3354.
23. Martin J, Trowbridge A, European Society of Clinical Investigation. Meeting. Platelet Heterogenity: biology and pathology. London; New York: Springer-Verlag; 1990.
24. Lackie JM. A dictionary of biomedicine. 1st ed. Oxford: Oxford University Press; 2010.
25. Best MG, Sol N, Kooi I, et al. RNA-Seq of Tumour-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics. Cancer Cell 2015; 28: 666-676.
26. Lopez-Vilchez I, Diaz-Ricart M, Galan AM, et al. Internalisation of Tissue Factor-Rich Microvesicles by Platelets Occurs Independently of GPIIb-IIIa, and Involves CD36 Receptor, Serotonin Transporter and Cytoskeletal Assembly. J Cell Biochem 2016; 117: 448-457.
27. Berg M, Offermanns S, Seifert R, Schultz G. Synthetic lipopeptide Pam3CysSer(Lys)4 is an effective activator of human platelets. Am J Physiol 1994; 266: C1684-1691.
28. Rex S, Beaulieu LM, Perlman DH, et al. Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular proteinprotein interactions, and alpha-granule release. Thromb Haemost 2009; 102: 97-110.
29. Blair P, Rex S, Vitseva O, et al. Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ Res 2009; 104: 346-354.
30. Brown GT, Narayanan P, Li W, et al. Lipopolysaccharide stimulates platelets through an IL-1beta autocrine loop. J Immunol 2013; 191: 5196-5203.
31. Michelson AD, Barnard MR, Hechtman HB, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93: 11877-11882.
32. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006; 20: 1-26.
33. Heijnen HF, Schiel AE, Fijnheer R, et al. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999; 94: 3791-3799.
34. Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C, et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun 2011; 2: 282.
35. Kelly PN, White MJ, Goschnick MW, et al. Individual and overlapping roles of BH3-only proteins Bim and Bad in apoptosis of lymphocytes and platelets and in suppression of thymic lymphoma development. Cell Death Differ 2010; 17: 1655-1664.
36. Kodama T, Takehara T, Hikita H, et al. BH3-only activator proteins Bid and Bim are dispensable for Bak/Bax-dependent thrombocyte apoptosis induced by BclxL deficiency: molecular requisites for the mitochondrial pathway to apoptosis in platelets. J Biol Chem 2011; 286: 13905-13913.
37. Koenig MN, Naik E, Rohrbeck L, et al. Pro-apoptotic BIM is an essential initiator of physiological endothelial cell death independent of regulation by FOXO3. Cell Death Differ 2014; 21: 1687-1695.
38. Walsh K, Smith RC, Kim HS. Vascular cell apoptosis in remodelling, restenosis, and plaque rupture. Circ Res 2000; 87: 184-188.
39. Morrison ME, Palenski TL, Jamali N, et al. Modulation of vascular cell function by bim expression. Int J Cell Biol 2013; 2013: 297537.
40. Boyanova D, Nilla S, Birschmann I, et al. PlateletWeb: a systems biologic analysis of signaling networks in human platelets. Blood 2012; 119: e22-34.
41. Kirschbaum M, Karimian G, Adelmeijer J, et al. Horizontal RNA transfer mediates platelet-induced hepatocyte proliferation. Blood 2015; 126: 798-806.
42. Shioiri T, Muroi M, Hatao F, et al. Caspase-3 is activated and rapidly released from human umbilical vein endothelial cells in response to lipopolysaccharide. Biochim Biophys Acta 2009; 1792: 1011-1018.
43. Peng J, Friese P, Heilmann E, et al. Aged platelets have an impaired response to thrombin as quantitated by P-selectin expression. Blood 1994; 83: 161-166.
44. Thompson CB, Jakubowski JA, Quinn PG, et al. Platelet size and age determine platelet function independently. Blood 1984; 63: 1372-1375.
45. Hirsh J. Platelet age: its relationship to platelet size, function and metabolism. Br J Haematol 1972; 23 (Suppl): 209-214.
46. Qiao J, Liu Y, Li D, et al. Imbalanced expression of Bcl-xL and Bax in platelets treated with plasma from immune thrombocytopenia. Immunol Res 2016; 64: 604-609.
47. Michalik KM, You X, Manavski Y, et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res 2014; 114: 1389-1397.
48. Guthikonda S, Alviar CL, Vaduganathan M, et al. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 2008; 52: 743-749.
49. Guthikonda S, Lev EI, Patel R, et al. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. J Thromb Haemost 2007; 5: 490-496.
50. Kim YG, Suh JW, Yoon CH, et al. Platelet volume indices are associated with high residual platelet reactivity after antiplatelet therapy in patients undergoing percutaneous coronary intervention. J Atheroscler Thromb 2014; 21: 445-453.
51. Huczek Z, Filipiak KJ, Kochman J, etal. Baseline platelet size is increased in patients with acute coronary syndromes developing early stent thrombosis and predicts future residual platelet reactivity. A case-control study. Thromb Res 2010; 125: 406-412.
52. Bray PF, McKenzie SE, Edelstein LC, et al. The complex transcriptional landscape of the anucleate human platelet. BMC Genomics 2013; 14: 1.